BioCentury
ARTICLE | Finance

Ebb & Flow

January 8, 2007 8:00 AM UTC

Cowen was no slouch on the biotech financing front in 2006, underwriting at least $2 billion of the sector's IPOs, follow-ons and private placements/registered directs. Now, the firm hopes to add another leg to its business via the formation of Cowen Healthcare Royalty Partners.

Two of the founders of CHRP - Todd Davis and Clarke Futch - clearly know that business. They came over from Paul Capital, where they were focused on the firm's royalty business. Both will be managing directors at Cowen and principals of CHRP. ...